Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Special Report 3 Blue-Chip Stocks Built for a Rotating MarketWritten by Chris Markoch. Originally Published: 3/8/2026. 
What You Need to Know - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
Sector rotation occurs when investors shift money out of sectors that look overbought and into ones that appear undervalued. In 2026, that has meant a rotation away from mega-cap technology stocks and toward value-oriented names, particularly in defensive sectors such as energy and consumer staples. The key word is overvalued. Big tech has been running hot for more than two years thanks to the emergence of artificial intelligence (AI). Despite concerns about a repeat of the dot-com bubble, many investors largely ignored the lofty valuations of these stocks. But valuation often doesn't matter until it does. As the economy starts to heat up, investors are seeking value elsewhere — including in blue-chip defensive names such as the stocks listed below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a well-known utility provider in the Southeast and Midwest United States. Utilities stocks are among the most defensive and are typically viewed as value and income plays. Duke Energy, for example, offers a secure dividend that yields around 3.2% and has increased its payout for 20 consecutive years. The changing U.S. energy landscape also creates opportunities for future growth at Duke. The company pursues an "all of the above" strategy that includes nuclear, hydroelectric and natural gas generation. Natural gas has helped drive the stock's strong bounce in 2026, but Duke's steady revenue base from its residential utility business — along with projected growth in areas such as data centers — is what makes DUK a sector-rotation target. DUK stock is up nearly 12% in 2026, putting it within about 5% of its consensus price target of $136.87, which would push the shares above their 52-week high. Trading at roughly 20.5x earnings, the stock sits at a slight premium to its historical average. Since Duke reported earnings in February, analysts have been raising price targets as they expect strong year-over-year revenue growth in the second half of the year — a development that could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotechnology names to benefit from the current rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within the healthcare sector, which has largely underperformed the broader market. Gilead is a leading provider of HIV therapies, with key drugs protected by patents into the 2030s. Investors are also encouraged by the company's pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch a CAR-T therapy for multiple myeloma in 2026 and may receive a label expansion for its breast cancer drug, Trodelvy. GILD is up nearly 18% in 2026, a run that pushed the stock to a 52-week high; it is now a bit below that peak — likely the result of some profit-taking after the outsized gain — which could create a buy-the-dip opportunity. Analysts have a consensus price target of $156.72 on GILD, implying a gain of just over 8%. Since the company's February earnings report, many analysts have raised targets, with the highest estimates near $170. Gilead also pays a dependable dividend yielding about 2.28% and has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been one of the biggest beneficiaries of the 2026 rotation into consumer staples. HSY is up nearly 25% this year and has broken out of the bearish trend that began in 2023. That downturn followed several quarters of pressure from higher cocoa costs that extended through 2025. Those elevated input costs will still weigh on earnings in 2026, but the market tends to look forward, and analysts are forecasting stronger earnings and revenue this year. HSY is trading above its consensus price target of $222.21, yet analysts have continued to raise targets since the company's February report. The most bullish call comes from Goldman Sachs, which has a $267 target. In its latest report, Hershey increased the dividend by 5.9%, marking the 15th consecutive annual increase. The stock yields roughly 2.5% and pays an annual dividend of $5.81 per share. Following the recent rally, HSY trades at a valuation above 50x earnings — a likely factor behind heavy institutional selling last quarter — but that elevated multiple could also give investors a chance to buy on any pullback.
| 
